Log in

Atrion Stock Price, Forecast & Analysis (NASDAQ:ATRI)

$728.51
-10.39 (-1.41 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$727.66
Now: $728.51
$741.00
50-Day Range
$724.30
MA: $789.83
$848.00
52-Week Range
$671.05
Now: $728.51
$948.03
Volume6,400 shs
Average Volume11,099 shs
Market Capitalization$1.35 billion
P/E Ratio38.56
Dividend Yield0.82%
Beta0.2
Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ATRI
CUSIP04990410
Phone972-390-9800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$152.45 million
Cash Flow$22.60 per share
Book Value$125.24 per share

Profitability

Net Income$34.26 million

Miscellaneous

Employees570
Market Cap$1.35 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableNot Optionable

Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter.


Atrion (NASDAQ:ATRI) Frequently Asked Questions

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion announced a quarterly dividend on Tuesday, November 12th. Investors of record on Monday, December 2nd will be given a dividend of $1.55 per share on Monday, December 16th. This represents a $6.20 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend is Friday, November 29th. View Atrion's Dividend History.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) posted its earnings results on Friday, November, 1st. The medical instruments supplier reported $5.15 EPS for the quarter. The medical instruments supplier had revenue of $38.88 million for the quarter. Atrion had a return on equity of 16.45% and a net margin of 23.43%. View Atrion's Earnings History.

When is Atrion's next earnings date?

Atrion is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Atrion.

Has Atrion been receiving favorable news coverage?

Media coverage about ATRI stock has been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Atrion earned a coverage optimism score of -1.3 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Atrion.

Who are some of Atrion's key competitors?

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include Opko Health (OPK), ABM Industries (ABM), Boston Beer (SAM), AngioDynamics (ANGO), Michaels Companies (MIK), Alaska Air Group (ALK), Chemed (CHE), Walt Disney (DIS), At Home Group (HOME) and Lennox International (LII).

Who are Atrion's key executives?

Atrion's management team includes the folowing people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 81)
  • Mr. David A. Battat, Pres & CEO (Age 49)
  • Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 60)

Who are Atrion's major shareholders?

Atrion's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (0.72%), Pennsylvania Trust Co (0.56%), Rhumbline Advisers (0.37%), First Trust Advisors LP (0.29%), California Public Employees Retirement System (0.22%) and SG Americas Securities LLC (0.17%). Company insiders that own Atrion stock include Jeffery Strickland and Ronald Nicholas Spaulding. View Institutional Ownership Trends for Atrion.

Which institutional investors are selling Atrion stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Virginia Retirement Systems ET AL, First Quadrant L P CA and Eagle Ridge Investment Management. Company insiders that have sold Atrion company stock in the last year include Jeffery Strickland and Ronald Nicholas Spaulding. View Insider Buying and Selling for Atrion.

Which institutional investors are buying Atrion stock?

ATRI stock was bought by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Rhumbline Advisers, Nisa Investment Advisors LLC, California Public Employees Retirement System, OLD Dominion Capital Management Inc., Boston Trust Walden Corp, Dean Capital Investments Management LLC and Russell Investments Group Ltd.. View Insider Buying and Selling for Atrion.

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $728.51.

How big of a company is Atrion?

Atrion has a market capitalization of $1.35 billion and generates $152.45 million in revenue each year. Atrion employs 570 workers across the globe.View Additional Information About Atrion.

What is Atrion's official website?

The official website for Atrion is http://www.atrioncorp.com/.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]


MarketBeat Community Rating for Atrion (NASDAQ ATRI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  102 (Thanks for Voting!)
Underperform Votes:  114 (Thanks for Voting!)
Total Votes:  216
MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel